Ahead of Reuters Pharma 2022, Antonio Iervolino, Partner out of our Putnam London office describes 5 major shifts that pharma companies will have to embrace as they design the path to market for their novel assets and provides an analysis on pharma product launches since 2018, identifying trends and measuring their performance against pre-launch expectations.
Antonio distills the key drivers that are critical in developing a virtuous value creating system and designing impactful go-to-market strategies for tomorrow’s healthcare ecosystems.
Read more on the thoughtful analysis and hear from Antonio at Pharma 2022 next week.
Jump to a slide with the slide dots.
Explore key themes from MAPS Americas 2025—advancing health equity, AI, and collaboration in Medical Affairs.
Read moreExplore MedAffairs 2025 insights: AI, omnichannel strategy & impact driving pharma success and better patient outcomes.
Read moreIndustry leaders discuss breaking barriers in health equity, inclusive research, and patient access at Inizio’s NYC panel.
Read more